Skip to main content
Equibles
USNA logo

USNA · Usana Health Sciences Inc

Track USNA — free

Use USNA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about USNA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$13.37 -0.26 (-1.91%) At close · Aug 14
Market Cap
$247.03M
Shares
18.48M

Usana Health Sciences Inc Earnings Call Transcripts

Every quarterly earnings call for Usana Health Sciences Inc (USNA) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼14.7% $227.96M $12.79M '22 Q4 22-02-08 ▼9% $248.36M $18.38M '23 Q1 22-07-26 ▼9.9% $238.20M $17.29M '23 Q2 22-10-25 ▼8.5% $213.37M $11.35M '23 Q3 23-01-05 ▼3% $221.08M $16.77M '23 Q4 23-04-25 ▼8.3% $227.80M $16.54M '24 Q1 23-07-25 ▼10.6% $212.87M $10.43M '24 Q2 23-10-24 ▼3.4% $213.61M $4.45M '24 Q4 24-04-30 ▲9.5% $249.54M $9.40M '25 Q1 24-07-23 ▲10.8% $235.85M $9.65M '25 Q2 24-10-22 ▲5.9% $226.20M −$1.77M '25 Q4 25-04-22 ▲0.3% $250.22M $7.51M '26 Q1 25-07-22 LATEST ▼5.3% $223.27M −$21.38M '26 Q2 25-10-09
Earnings call
FY27 · Q2
2026-08-05
Q2 2026 USANA Health Sciences Earnings Conference Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY27 · Q1
2026-05-06
Usana Health Sciences Inc Q1 FY2027 Earnings Call
Confident tone Rise Wellness / ProteinPop retail expansion Haya (HIA) omni-channel brand Core nutritional business stabilization
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-02-18
Usana Health Sciences Inc Q3 FY2026 Earnings Call
Positive tone Rise Wellness and Haya growth Leadership transition and renewed strategic focus Fiscal 2026 sales outlook
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q2
2025-10-09
Usana Health Sciences Inc Q2 FY2026 Earnings Call
Revenue
$223.27M
▼ 5.3% YoY
Diluted EPS
$-1.16
▼ 323.1% YoY
Gross margin
78.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-07-22
Usana Health Sciences Inc Q1 FY2026 Earnings Call
Positive tone Rise Wellness and ProteinPop Retail expansion Core nutritional stabilization
Revenue
$250.22M
▲ 0.3% YoY
Diluted EPS
$0.41
▼ 16.3% YoY
Gross margin
76.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-04-22
Usana Health Sciences Inc Q4 FY2025 Earnings Call
Positive tone Fiscal 2026 Outlook and Net Sales Growth Guidance Hiya Venture Growth Rise Wellness / Protein Pop Expansion
Revenue
$226.20M*
▲ 5.9% YoY
Gross margin
78.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q2
2024-10-22
Usana Health Sciences Inc Q2 FY2025 Earnings Call
Confident tone Brand Partner Strategy & Compensation Hiya Acquisition M&A Pipeline & AI Tools
Revenue
$235.85M
▲ 10.8% YoY
Diluted EPS
$0.52
▼ 3.7% YoY
Gross margin
78.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-07-23
Usana Health Sciences Inc Q1 FY2025 Earnings Call
Positive tone Tariffs and trade policy exposure Hiya acquisition and growth China market performance
Revenue
$249.54M
▲ 9.5% YoY
Diluted EPS
$0.49
▼ 43% YoY
Gross margin
79.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-04-30
Usana Health Sciences Inc Q4 FY2024 Earnings Call
Positive tone Hyatt Acquisition Product Innovation and Launches Associate Incentives and Engagement
Revenue
$213.61M*
▼ 3.4% YoY
Gross margin
82.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2023-10-24
Usana Health Sciences Inc Q2 FY2024 Earnings Call
Revenue
$212.87M
▼ 10.6% YoY
Diluted EPS
$0.54
▼ 39.3% YoY
Gross margin
81.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2023-07-25
Usana Health Sciences Inc Q1 FY2024 Earnings Call
Revenue
$227.80M
▼ 8.3% YoY
Diluted EPS
$0.86
▼ 9.5% YoY
Gross margin
81.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-04-25
Usana Health Sciences Inc Q4 FY2023 Earnings Call
Revenue
$221.08M*
▼ 3% YoY
Gross margin
80.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-01-05
Usana Health Sciences Inc Q3 FY2023 Earnings Call
Revenue
$213.37M
▼ 8.5% YoY
Diluted EPS
$0.59
▼ 24.4% YoY
Gross margin
80.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-10-25
Usana Health Sciences Inc Q2 FY2023 Earnings Call
Revenue
$238.20M
▼ 9.9% YoY
Diluted EPS
$0.89
▼ 11% YoY
Gross margin
81.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-07-26
Usana Health Sciences Inc Q1 FY2023 Earnings Call
Revenue
$248.36M
▼ 9% YoY
Diluted EPS
$0.95
▼ 17.4% YoY
Gross margin
80.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-02-08
Usana Health Sciences Inc Q4 FY2022 Earnings Call
Revenue
$227.96M*
▼ 14.7% YoY
Gross margin
79.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2021-10-26
Usana Health Sciences Inc Q2 FY2022 Earnings Call
Revenue
$264.47M
▼ 21.5% YoY
Diluted EPS
$1.00
▼ 46.5% YoY
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-07-27
Usana Health Sciences Inc Q1 FY2022 Earnings Call
Revenue
$272.87M
▼ 11.4% YoY
Diluted EPS
$1.15
▼ 20.7% YoY
Gross margin
81.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-04-27
Usana Health Sciences Inc Q4 FY2021 Earnings Call
Revenue
$267.30M*
▼ 13.9% YoY
Gross margin
80.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q2
2020-10-20
Usana Health Sciences Inc Q2 FY2021 Earnings Call
Revenue
$336.84M
▲ 30.1% YoY
Diluted EPS
$1.87
▲ 41.7% YoY
Gross margin
83.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2020-07-21
Usana Health Sciences Inc Q1 FY2021 Earnings Call
Revenue
$307.98M
▲ 15.5% YoY
Diluted EPS
$1.45
▲ 17.9% YoY
Gross margin
81.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-02-04
Usana Health Sciences Inc Q4 FY2020 Earnings Call
Revenue
$310.52M*
▲ 14.5% YoY
Gross margin
81.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q1
2019-04-30
Usana Health Sciences Inc Q1 FY2020 Earnings Call
Revenue
$266.62M
▼ 2.3% YoY
Diluted EPS
$1.23
▲ 21.8% YoY
Gross margin
82.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts CIK 896264 CUSIP 90328M107 13F (30d) 129 filings 128 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)